Sequencing of commercially-available pancreatic cancer cell lines reveals selective CYP3A5 overexpression among xenobiotic-metabolizing CYPs.
Ontology highlight
ABSTRACT: Sequencing of commercially-available pancreatic cancer cell lines reveals selective CYP3A5 overexpression among xenobiotic-metabolizing CYPs.
PROVIDER: PRJNA575858 | ENA |
REPOSITORIES: ENA
ACCESS DATA